CompareSkinVisionvsLegit.Health

SkinVision is a consumer-facing AI dermatology app that assesses skin lesion risk from smartphone photos and routes users toward in-person dermatology when needed. The product is positioned around lesion triage, monitoring, or workflow support rather than autonomous dermatology, and in-person dermatology assessment remains essential for any suspect or evolving skin finding. Buyers should confirm intended use scope, image capture standards, regulatory framing by market, and clinician oversight model before deploying across patient-facing or clinical settings.

For consumers monitoring skin lesions at home, SkinVision is worth a serious look thanks to smartphone-based lesion risk assessment. The honest trade-off is that not a substitute for in-person dermatology. A free tier is available, with paid plans for expanded use. Buyers should still verify EHR or workflow fit, scope, and support before committing.

Legit.Health is a clinical-grade dermatology AI platform that supports lesion assessment, scoring, and severity tracking in dermatology and primary care. The product is positioned around lesion triage, monitoring, or workflow support rather than autonomous dermatology, and in-person dermatology assessment remains essential for any suspect or evolving skin finding. Buyers should confirm intended use scope, image capture standards, regulatory framing by market, and clinician oversight model before deploying across patient-facing or clinical settings.

Buyers comparing Legit.Health should map severity scoring plus lesion tracking against dermatology specialists and primary care users, and then weigh that regional regulatory scope varies. Pricing is sales-led and scoped per buyer rather than posted publicly. A focused pilot, scoped to one workflow, is usually the cleanest way to test fit.